These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6164250)

  • 21. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S; Takahashi R; Masumura I; Miike A
    Folia Psychiatr Neurol Jpn; 1976; 30(4):463-73. PubMed ID: 1088138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central serotonin deficiency--a factor which increases depression vulnerability?
    van Praag HM; de Haan S
    Acta Psychiatr Scand Suppl; 1980; 280():89-96. PubMed ID: 6157306
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls.
    Croonenberghs J; Verkerk R; Scharpe S; Deboutte D; Maes M
    Life Sci; 2005 Mar; 76(19):2171-83. PubMed ID: 15733932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression.
    Fawcett JA
    J Clin Psychiatry; 2003; 64 Suppl 5():32-7. PubMed ID: 12720482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients.
    Peselow ED; Dunner DL; Fieve RR; Lautin A
    Am J Psychiatry; 1982 Jun; 139(6):747-52. PubMed ID: 6805339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 5-hydroxytryptophan on H-reflex recovery curves in normal subjects and patients with affective disorders.
    Metz JT; Holcomb HH; Meltzer HY
    Biol Psychiatry; 1988 Mar; 23(6):602-11. PubMed ID: 3128339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central monoamine metabolism in depressions. I. Serotonin and related compounds.
    van Praag HM
    Compr Psychiatry; 1980; 21(1):30-43. PubMed ID: 6153593
    [No Abstract]   [Full Text] [Related]  

  • 28. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Hydroxytryptophan: a clinically-effective serotonin precursor.
    Birdsall TC
    Altern Med Rev; 1998 Aug; 3(4):271-80. PubMed ID: 9727088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of 5-hydroxytryptophan in the isolated perfused rat lung.
    Ben-Harari RR; Parent Ermini A; Kleinerman J
    Pharmacology; 1990; 41(5):272-9. PubMed ID: 1709288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amitriptyline and isocarboxazid on 5-hydroxytryptophan induced head twitches in mice.
    Nakamura M; Fukushima H; Kitagawa S
    Psychopharmacology (Berl); 1976 Jul; 48(1):101-4. PubMed ID: 823564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW; MacDonald MR
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract]   [Full Text] [Related]  

  • 33. Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism--a preliminary study.
    Keszthelyi D; Troost FJ; Jonkers DM; van Eijk HM; Dekker J; Buurman WA; Masclee AA
    Neurogastroenterol Motil; 2015 Aug; 27(8):1127-37. PubMed ID: 26031193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
    Löscher W; Pagliusi SR; Müller F
    Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium discontinuation, serum cortisol, and 5-HTP.
    Goodnick PJ; Fieve RR; Schlegel A
    Biol Psychiatry; 1987 Feb; 22(2):240-1. PubMed ID: 3493037
    [No Abstract]   [Full Text] [Related]  

  • 36. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate.
    Goodnick PJ; Fieve RR; Schlegel A; Baxter N
    Am J Psychiatry; 1987 Mar; 144(3):367-9. PubMed ID: 3103474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic medication for unipolar depressive illness: the place of lithium carbonate in combination with antidepressant medication.
    Kim HR; Delva NJ; Lawson JS
    Can J Psychiatry; 1990 Mar; 35(2):107-14. PubMed ID: 2138503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
    J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Hydroxytrytophan as an antidepressant. The predictive value of the probenecid test.
    van Praag HM; Korf J
    J Nerv Ment Dis; 1974 May; 158(5):331-7. PubMed ID: 4596091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.